The renal circulation undergoes significant changes during pregnancy a
nd pregnancy-induced hypertension. Although numerous studies indicate
that the presser response to angiotensin II (Aug II) is reduced during
pregnancy, it is unclear as to whether this altered sensitivity to An
g II occurs in the renal circulation. The first aim of this study was
to determine whether the renal vascular responsiveness to exogenous An
g II is altered in the midterm pregnant rat. AU rats were pretreated w
ith an intravenous infusion of the converting-enzyme inhibitor captopr
il (20 mu g.kg(-1).min(-1)) to block endogenous Ang II formation. Foll
owing a control period, Ang II was infused at a dose of 10 ng.kg(-1).m
in(-1) for 50 minutes into the renal arteries via a suprarenal aortic
catheter. In anesthetized virgin rats, Ang II markedly decreased renal
plasma flow (RPF) by 39% (5.0 +/- 0.4 to 3.1 +/- 0.4 mL/min), glomeru
lar filtration rate (GFR) by 39% (1.9 +/- 0.1 to 1.16 +/- 0.2 mL/min),
and urine flow by 47% (22.1 +/- 5.6 to 12.3 +/- 4.8 mu L/min). In con
trast, Ang II had no significant effect on RPF, GFR, and urine flow in
the anesthetized pregnant rats. Since nitric oxide (NO) has been prev
iously reported to modulate the renal vascular actions of Ang II in no
rmal animals and NO synthesis is thought to be elevated in preg nancy,
this study examined the role of NO in the attenuated renal response t
o Ang II. In pregnant rats pretreated with L-NAME, the arterial pressu
re was higher and RPF was lower than in the control pregnant rats. How
ever, the renal response to Ang II in the L-NAME-pretreated pregnant r
ats was similar to control pregnant rats. These data indicate that the
renal circulation has a reduced sensitivity to Ang II during pregnanc
y. We also found that NO synthesis inhibition does not alter the atten
uated renal response to Ang II in the anesthetized pregnant rats.